MAPT and Alzheimer disease: The CSF AD biomarkers, i.e., Aβ1-42, T-tau, and P-tau181, correlated with the brain biopsy AD pathology as expected, but were systematically lower in the iNPH patients when compared to the controls (Figure 1).